Banka BioLoo growth ratios

·UnclassifiedChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+5.4%+8.4%+18.1%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+280.9%−179.2%−39.0%
+144.3%−475.9%−67.8%
+104.4%−1,227.5%−126.4%
+103.9%−1,468.3%−74.9%
+22.6%+6.1%+18.7%
+34.8%−20.6%−0.8%
+21.2%−68.8%−70.9%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BANKA₹62.50

Banka BioLoo Limited

· Unclassified
₹ CrorePeersRAJMETAAKASHGLOBEGRADIENTEMOKSHARTNIRMANAJOONIBEARDSELLMcap ₹68.3 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—+18.1+8.4+5.4—
EBITDA Growth—-39.0-179.2+280.9—
EBIT Growth—-67.8-475.9+144.3—
Net Income Growth—-126.4-1,227.5+104.4—
EPS Growth—-74.9-1,468.3+103.9—
Total Assets Growth—+18.7+6.1+22.6—
Total Equity Growth—-0.8-20.6+34.8—
Cash from Operations Growth—-70.9-68.8+21.2—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.